5 Einträge gefunden

1. Generalized pustular psoriasis: overview of the status quo and results of a panel discussion

   1. Reich, Kristian
   2. Augustin, Matthias
   3. Gerdes, Sascha
   4. Ghoreschi, Kamran
   5. Kokolakis, Georgios
   6. Mößner, Rotraut
   7. Mrowietz, Ulrich

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Secukinumab dosing every 2 weeks demonstrated superior efficacy compared with dosing every 4 weeks in patients with psoriasis weighing 90 kg or more: results of a randomized controlled trial

   1. Augustin, Matthias
   2. Reich, Kristian
   3. Yamauchi, Paul
   4. Pinter, Andreas
   5. Bagel, Jerry
   6. Dahale, Swapnil
   7. You, Ruquan

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. IL-23 blockade with guselkumab potentially modifies psoriasis pathogenesis: rationale and study protocol of a phase 3b, randomised, double-blind, multicentre study in participants with moderate-to-severe plaque-type psoriasis (GUIDE)

   1. Eyerich, Kilian
   2. Weisenseel, Peter
   3. Pinter, Andreas
   4. Schäkel, Knut
   5. Asadullah, Khusru
   6. Wegner, Sven
   7. Muñoz-Elias, Ernesto J

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Study

   1. Mrowietz, Ulrich
   2. Burden, A David
   3. Pinter, Andreas
   4. Reich, Kristian
   5. Schäkel, Knut
   6. Baum, Patrick
   7. Datsenko, Yakov

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
5. Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial

   1. Gordon, Kenneth B
   2. Foley, Peter
   3. Krueger, James G
   4. Pinter, Andreas
   5. Reich, Kristian
   6. Vender, Ronald
   7. Vanvoorden, Veerle

   2021 - Forschungsinformationssystem des UKE